Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H27ClN2.C4H4O4 |
Molecular Weight | 470.988 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C\C(O)=O.CN1CCN(CC1(C)C)[C@@H]2C[C@H](C3=C2C=C(Cl)C=C3)C4=CC=CC=C4
InChI
InChIKey=PSDXTSHOYHAMTE-VFHZDWIZSA-N
InChI=1S/C22H27ClN2.C4H4O4/c1-22(2)15-25(12-11-24(22)3)21-14-19(16-7-5-4-6-8-16)18-10-9-17(23)13-20(18)21;5-3(6)1-2-4(7)8/h4-10,13,19,21H,11-12,14-15H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t19-,21+;/m0./s1
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01295372
7.5 mg/day
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
300000013054
Created by
admin on Fri Dec 15 16:02:26 GMT 2023 , Edited by admin on Fri Dec 15 16:02:26 GMT 2023
|
PRIMARY | |||
|
354Q3TY534
Created by
admin on Fri Dec 15 16:02:26 GMT 2023 , Edited by admin on Fri Dec 15 16:02:26 GMT 2023
|
PRIMARY | |||
|
67266632
Created by
admin on Fri Dec 15 16:02:26 GMT 2023 , Edited by admin on Fri Dec 15 16:02:26 GMT 2023
|
PRIMARY | |||
|
170381-17-6
Created by
admin on Fri Dec 15 16:02:26 GMT 2023 , Edited by admin on Fri Dec 15 16:02:26 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD